Long-Term Outcome of Patients with Lupus Nephritis: A Single Center Experience

Long-Term Outcome of Patients with Lupus Nephritis: A Single Center Experience

Lupus nephritis (LN) is an immune inflammation of kidneys caused by systemic lupus erythematosus (SLE), a chronic inflammatory disease that affects the body’s immune system. Aim of this study was to analyze clinical manifestation and treatment results of patients with LN. Forty one patients with cl...

Full description

Bibliographic Details
Main Authors:	Senija Rašić, Amira Srna, Snežana Unčanin, Jasminka Džemidžić, Damir Rebić, Alma Muslimović, Maida Rakanović-Todić, Aida Hamzić-Mehmedbašić
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2010-04-01
Series:	Biomolecules & Biomedicine
Subjects:	lupus nephritis cyclophosphamide mycophenolate mofetil treatment outcome
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/2651

Similar Items

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
by: Xiaohui Zhang, et al.
Published: (2023-07-01)

Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria
by: Kristina Vollbach, et al.
Published: (2022-04-01)

Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
by: Siqin Sun, et al.
Published: (2024-12-01)

Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center
by: Keerthi Talari, et al.
Published: (2017-01-01)

Comparison of mycophenolic acid with cyclophosphamide for the treatment of pediatric lupus nephritis: A retrospective study from a tertiary center hospital in Taiwan
by: Huei-Geng Chen, et al.
Published: (2023-10-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
by: Tomoko Mizaki, et al.
Published: (2023-01-01)

The scarcity dilemma in lupus nephritis: A rare case of diffuse alveolar hemorrhage and its multitargeted management
by: Thannushree Aritakulu Badrinath, et al.
Published: (2024-08-01)

Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis
by: Kang Li, et al.
Published: (2022-04-01)

Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies
by: Tak Mao eChan, et al.
Published: (2015-09-01)

Assessment of the Potential Impact of Mycophenolate Mofetil on Lowering Renal Biomarkers in Patients with Class III Lupus Nephritis: A Pilot Study to Predict Renal Function Progress
by: Nadia H. Mohammed, et al.
Published: (2024-09-01)

Uso de micofenolato mofetil em pacientes com lúpus eritematoso sistêmico juvenil e nefrite refratária Use of mycophenolate mofetil in patients with juvenile systemic lupus erythematosus and refractory nephritis
by: Ricardo Maisse Suehiro, et al.
Published: (2004-10-01)

Predictors of Left Ventricular Remodelling in Kidney Transplant Recipents in the First Posttransplant Year
by: Jasminka Džemidžić, et al.
Published: (2010-04-01)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
by: Azar Nickavar, et al.
Published: (2017-07-01)

Monotypic IgG1-kappa Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Report
by: Maxim Olivier, et al.
Published: (2019-02-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
by: Chenzhu Zhang, et al.
Published: (2022-04-01)

Lupus nephritis - case report of an uncommon succession of therapies
by: Andreea Rovinaru, et al.
Published: (2023-12-01)

Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
by: Gurdeep Singh Dhooria, et al.
Published: (2024-09-01)

Incidence of serious infections in patients with ANCA-associated vasculitis receiving immunosuppressive therapy: A systematic review and meta-analysis
by: Athanasios Vassilopoulos, et al.
Published: (2023-03-01)

Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
by: Qing Jia, et al.
Published: (2022-08-01)

Low adherence to mycophenolic acid in patients with lupus nephritis: assessment using the 4-item Morisky Medication Adherence Scale and plasma levels
by: Florencia Oricchio, et al.
Published: (2023-01-01)

The Influence of Risk Factors in Remodelling Carotid Arteries in Patients Undergoing Peritoneal Dialysis
by: Damir Rebić, et al.
Published: (2010-04-01)

TO COMPARE THE EFFICACY OF MYCOPHENOLATEMOFETYL WITH CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF LUPUS NEPHRITIS
by: Dilshad Muhammad, et al.
Published: (2014-12-01)

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil
by: Mumina Akthar, et al.
Published: (2023-06-01)

Mycophenolate-induced colitis in a patient with lupus nephritis: a case report and review of the literature
by: Ziyad Alakkas, et al.
Published: (2024-05-01)

End of induction treatment outcomes with a novel cyclophosphamide-based regimen for severe lupus nephritis: Single-center experience from South India
by: V Jayaprakash, et al.
Published: (2020-01-01)

Chilblain lupus erythematosus – a case report
by: Natalia Zając, et al.
Published: (2015-03-01)

Effect of Intravenous Cyclophosphamide Pulse Therapy on Renal Functions and Histopathology in Patients with Severe Lupus Nephritis
by: Huraib Sameer, et al.
Published: (2000-01-01)

Induction therapy and outcome of proliferative lupus nephritis in the top end of Northern Australia – a single centre study retrospective study
by: Chi Xu, et al.
Published: (2022-07-01)

Management of connective tissue disease-associated interstitial lung disease
by: Keerthi Talari
Published: (2021-01-01)

Oral cyclophosphamide treatment for clinical periocular inflammation of unknown origin
by: Arash Maleki, et al.
Published: (2024-10-01)

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
by: Antoniya Kamenova, et al.
Published: (2023-03-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)

Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010)

Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide
by: Kittiphan Chienwichai, et al.
Published: (2024-09-01)

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al.

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of pediatric lupus nephritis: A cross-sectional study
by: Navamani Kirubakaran, et al.
Published: (2022-01-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

LESIONS OF THE HEMATOPOIETIC SYSTEM IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE EFFECTIVENESS OF TREATMENT WITH MYCOPHENOLATE MOFETIL
by: I.A. Mormol, et al.
Published: (2022-12-01)